RE-BVS – Piemonte Repository

Sfoglia per AUTORE
DI RENZO N
Collezione AO Cuneo

Items : 6

Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial. in Nature communications / Nat Commun. 2025 Mar 23;16(1):2846. doi: 10.1038/s41467-025-58179-6.

2025
AO Cuneo

Loges S; Heuser M; Chromik J; Sutamtewagul G; Kapp-Schwoerer S; Crugnola M; Di Renzo N; Lemoli R; Mattei D; Fiedler W; Alvarado-Valero Y; Ben-Batalla I; Waizenegger J; Rieckmann LM; Janning M; Collienne M; Imbusch CD; Beumer N; Micklem D; H Nilsson L; Madeleine N; McCracken N; Oliva C; Gorcea-Carson C; Gjertsen BT;

INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia. in Cancer / Cancer. 2025 Apr 1;131(7):e35820. doi: 10.1002/cncr.35820.

2025
AO Cuneo

Papayannidis C; Petracci E; Zappasodi P; Fracchiolla N; Ciceri F; Sartor C; Roncoroni E; Di Raimondo F; Mattei D; Giannini MB; Lanza F; Gottardi M; Del Principe MI; Borlenghi E; Fumagalli M; Vallisa D; Sica S; Di Renzo N; Fabbiano F; Todisco E; de Fabritiis P; Luppi M; Passamonti F; Corradini P; Petruzziello F; Pane F; Ferrara F; Mambelli G; Volpi R; et alii...

AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia. in Cancer / Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24.

2023
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Martinelli G; Rossi G; Volpi R; Sciumè M; Tarella C; Marconi G; Federico V; Romano A; Cardinali V; Gigli F; Roncoroni E; Ferrara F; Maurillo L; Nanni J; Rivellini F; Cascavilla N; Fianchi L; Cilloni D; Lanza F; Abruzzese E; Martini V; Lunghi M; Molteni A; Gottardi M; Salutari P; Cairoli R; Borlenghi E; Basilico CM; Manfra I; et alii...

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.

2020
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Corradini P; Pagano L; Bertù L; Corrao G; Grossi PA; Franchi M; Oberti M; Zappasodi P; Visco C; Armiento D; Pane F; Pinto A; Galieni P; Rigacci L; Candoni A; Venditti A; Fava C; Federici AB; Marchesi F; Musto P; Gentile M; Bocchia M; Di Renzo N; Olivieri A; Ferrandina C; Selleri C; Ortu La Barbera E; Luppi M; Scattolin AM; et alii...

Relapsing/refractory HL after autotransplantation: which treatment? in Acta bio-medica : Atenei Parmensis / Acta Biomed. 2020 May 25;91(S-5):30-40. doi: 10.23750/abm.v91iS-5.9912.

2020
AO Cuneo

Di Renzo N; Gaudio F; Carlo Stella C; Oppi S; Pelosini M; Sorasio R; Stelitano C; Rigacci L;

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma. in Oncotarget / Oncotarget. 2018 May 4;9(34):23443-23450. doi: 10.18632/oncotarget.25215. eCollection 2018 May 4.

2018
AO Cuneo
AOU Città della Salute di Torino

Castellino C; Mastrullo L; Marasca R; Santambrogio E; Vanazzi A; D'Alò F; Rigolin GM; Ilariucci F; Molica S; Cascavilla N; Tosi P; Di Renzo N; Baldini L; Zilioli VR; Paolini R; Visco C; Merli M; Pisani F; Spina F; Ferrero S; Volpetti S; Spina M; Gotti M; Sottotetti F; Morigi A; Casadei B; Broccoli A; Desabbata G; Scortechini I; et alii...